Eleison Pharmaceuticals Inc — Form D

Eleison Pharmaceuticals Inc of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-14. The offering totals $1.0M, of which $980K was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2022-09-14
Form: D
Accession: 0001682220-22-000001
Industry: Pharmaceuticals
Exemptions: 06b, 4a5
Total offering: $1.0M
Amount sold: $980K
Remaining: $20K
Minimum investment: $25K
Investors: 20
Date of first sale: 2022-04-28
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-458772

Issuer

Name: Eleison Pharmaceuticals Inc
CIK: 0001880047
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2020
Address: 100 OVERLOOK CENTER, 2ND FLOOR, PRINCETON, NJ, 08540
Phone: 215-554-3530

Officers, directors & promoters (10)

Name	Role	Location
Joel Allen Morganroth	Director	Princeton, NJ
Michael J Otto	Director	Princeton, NJ
Frank J Seidman	Director	Princeton, NJ
Edwin J Thomas	Director	Princeton, NJ
Bryan R Wood	Director	Princeton, NJ
Matthew Allen Cromie	Executive Officer	Princeton, NJ
William Vincent Fricker	Executive Officer	Princeton, NJ
Michael E Lusty	Executive Officer	Princeton, NJ
Patrick E Maguire	Executive Officer	Princeton, NJ
Edwin J Thomas	Executive Officer	Princeton, NJ

More